SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

TG Therapeutics, Inc. TGTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

TG Therapeutics, Inc. (TGTX) has 11 identified peers for comparison in the Healthcare sector. Peers include AKRO, BTAI, EXEL, HEPA, ICPT, MDGL and others.

TGTX has a market capitalization of $5.52B, compared to an average peer market cap of $4.11B.

Peers & Similar Companies — TGTX

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

BioXcel Therapeutics, Inc.

$1.06 +3.92% $28.7M

$45.86 +2.00% $12.3B

Hepion Pharmaceuticals, Inc.

$0.05 +18.52% $557.78K

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

PDS Biotechnology Corporation

$1.06 -2.75% $59.16M

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

Terns Pharmaceuticals, Inc.

$52.68 +0.13% $4.75B

Viking Therapeutics, Inc.

$35.52 +1.46% $4.1B

X4 Pharmaceuticals, Inc.

$4.20 +1.69% $47.91M

People Also View

Madrigal Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

Akero Therapeutics, Inc.

Viking Therapeutics, Inc.

Intercept Pharmaceuticals, Inc.

PDS Biotechnology Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message